ChromaDex (CDXC) Misses Q4 EPS by 4c

ChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Ennis (EBF) Reports In-Line Q1 EPS
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook